Biogen Inc. (NASDAQ:BIIB).
Swedbank sold 48,930 shares last quarter decreasing its exposure to Biogen Inc. by 7.8%. Its investment was worth $156,961,000 a decrease of $14,570,000 as of the end of the quarter.
Here are a few other firms who have updated their positions. Gateway Investment Advisers LLC grew its stake by buying 15,260 shares an increase of 10.5% as of 06/30/2017. Gateway Investment Advisers LLC currently owns 160,003 shares worth $43,418,000. The total value of its holdings increased 9.7%. As of the end of the quarter Hills Bank & Trust Co had bought a total of 197 shares growing its holdings by 5.0%. The value in dollars went from $1,067,000 to $1,112,000 increasing 4.2% quarter to quarter.
Clinton Group Inc divested its holdings by selling 16,382 shares a decrease of 82.3% in the quarter. Clinton Group Inc claims 3,533 shares with a value of $965,000. The value of the position overall is down by 82.9%.
July 11 investment analysts at Morgan Stanley held the stock rating at “Equal-Weight” and lowered the price expectation to $301.00 from $368.00. On June 19 the company was upgraded from “Neutral” to “Buy” in a statement from UBS.
Equity analyst Mizuho started covering BIIB with a rating of “Overweight”. On November 7 the stock rating was upgraded to “Outperform” from “Market Perform” in an announcement from Leerink Swann.
On November 7, 2016 the stock rating was changed to a “Overweight” according to a PiperJaffray report up from the previous “” rating. On September 6 the company was rated “Hold” in a report from Jefferies which was a cut from the previous “Buy” rating.
The company is now up by 0.66% since yesterday’s close of $271.76. It is currently trading at $273.55 marginally over $259.24, the 50 day moving average and barely below the 200 day moving average of $274.78. The 50 day moving average was up by +5.7731% and the 200 day average went down $-0.58 or -0.2102%.
The company currently has a P/E ratio of 17.1744 and the market value is 58.16B. In the last earnings report the EPS was $15.97 and is projected to be $20.48 for the current year with 212,115,000 shares currently outstanding. Next quarter’s EPS is forecasted to be $5.34 and the next full year EPS is projected to be $22.53.
Short traders are feeling a little more bearish on the company lately if you put credence in the motion in short interest. The firm recorded a rise in short interest of 23.23% as of the latest report on May 31, 2017. Short interest increased from 2,425,548 to 2,988,953 over that period. The days to cover increased to 1.9 and the short interest percentage is 0.01% as of May 31.